NCT06775080 2025-01-14The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal TumorsHuashan HospitalPhase 2 Recruiting40 enrolled
NCT06099821 2023-10-26KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 BlockadePeking University Cancer Hospital & InstitutePhase 2 Recruiting39 enrolled
NCT05624099 2023-10-19Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.Fujian Cancer HospitalPhase 2 Recruiting75 enrolled